NCT03598075View on ClinicalTrials.gov

Amylin and CGRP Head to Head Provocation in Migraine Without Aura Patients

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

December 31, 2019

Conditions
Migraine Without Aura
Interventions
OTHER

Amylin (Pramlintide)

Pramlintide is a amylin analog. It will be given intravenously at the rate of 120 micrograms over 20 minutes .

OTHER

CGRP

CGRP It will be given intravenously at the rate of 30 microgram over 20 minutes.

Trial Locations (1)

2600

Danish Headache Center, Glostrup Municipality

All Listed Sponsors
lead

Danish Headache Center

OTHER

NCT03598075 - Amylin and CGRP Head to Head Provocation in Migraine Without Aura Patients | Biotech Hunter | Biotech Hunter